Human, donkey and cow milk differently affects energy efficiency and inflammatory state by modulating mitochondrial function and gut microbiota by Trinchese, Giovanna et al.
Available at:
http://hdl.handle.net/2078.1/161960
[Downloaded 2019/04/19 at 04:58:30 ]
"Human, donkey and cow milk differently affects
energy efficiency and inflammatory state by
modulating mitochondrial function and gut microbiota"
Trinchese, Giovanna ; Cavaliere, Gina ; Canani, Roberto Berni ; Matamoros, Sébastien ;
Bergamo, Paolo ; De Filippo, Chiara ; Aceto, Serena ; Gaita, Marcello ; Cerino,
Pellegrino ; Negri, Rossella ; Greco, Luigi ; Cani, Patrice D. ; Mollica, Maria Pina
Abstract
Different nutritional components are able, by modulating mitochondrial function
and gut microbiota composition, to influence body composition, metabolic
homeostasis and inflammatory state. In this study, we aimed to evaluate the
effects produced by the supplementation of different milks on energy balance,
inflammatory state, oxidative stress and antioxidant/detoxifying enzyme activities
and to investigate the role of the mitochondrial efficiency and the gut microbiota in
the regulation of metabolic functions in an animal model. We compared the intake
of human milk, gold standard for infant nutrition, with equicaloric supplementation
of donkey milk, the best substitute for newborns due to its nutritional properties,
and cow milk, the primary marketed product. The results showed a hypolipidemic
effect produced by donkey and human milk intake in parallel with enhanced
mitochondrial activity/proton leakage. Reduced mitochondrial energy efficiency
and proinflammatory signals (tumor necros...
Document type : Article de périodique (Journal article)
Référence bibliographique
Trinchese, Giovanna ; Cavaliere, Gina ; Canani, Roberto Berni ; Matamoros, Sébastien ; Bergamo,
Paolo ; et. al. Human, donkey and cow milk differently affects energy efficiency and inflammatory
state by modulating mitochondrial function and gut microbiota.  In: The Journal of Nutritional
Biochemistry, Vol. 26, no. 11, p. 1136-1146 (2015)
DOI : 10.1016/j.jnutbio.2015.05.003
  	

Human, donkey and cow milk differently affects energy efficiency and
inflammatory state by modulating mitochondrial function and gut microbiota
Giovanna Trinchese, Gina Cavaliere, Roberto Berni Canani, Sebastien
Matamoros, Paolo Bergamo, Chiara De Filippo, Serena Aceto, Marcello
Gaita, Pellegrino Cerino, Rossella Negri, Luigi Greco, Patrice D. Cani, Maria
Pina Mollica
PII: S0955-2863(15)00136-9
DOI: doi: 10.1016/j.jnutbio.2015.05.003
Reference: JNB 7364
To appear in: The Journal of Nutritional Biochemistry
Received date: 3 October 2014
Revised date: 7 May 2015
Accepted date: 7 May 2015
Please cite this article as: Trinchese Giovanna, Cavaliere Gina, Canani Roberto Berni,
Matamoros Sebastien, Bergamo Paolo, De Filippo Chiara, Aceto Serena, Gaita Marcello,
Cerino Pellegrino, Negri Rossella, Greco Luigi, Cani Patrice D., Mollica Maria Pina, Hu-
man, donkey and cow milk diﬀerently aﬀects energy eﬃciency and inﬂammatory state
by modulating mitochondrial function and gut microbiota, The Journal of Nutritional Bio-
chemistry (2015), doi: 10.1016/j.jnutbio.2015.05.003
This is a PDF ﬁle of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its ﬁnal form. Please note that during the production process
errors may be discovered which could aﬀect the content, and all legal disclaimers that
apply to the journal pertain.
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
Human, donkey and cow milk differently affects energy efficiency and 
inflammatory state by modulating mitochondrial function and gut 
microbiota  
 
 
 
Giovanna Trinchese
1
, Gina Cavaliere
1
, Roberto Berni Canani
2
,
 
Sebastien Matamoros
3
, Paolo 
Bergamo
4
, Chiara De Filippo
1
, Serena Aceto
1
, Marcello Gaita
1
, Pellegrino Cerino
1
, Rossella Negri
2
, 
Luigi Greco
2
, Patrice D. Cani
3
 and Maria Pina Mollica
1 
 
1 Department of Biology, University of Naples “Federico II”,  Napoli, Italy. 
2 
Department of Translational Medical Sciences, European Laboratory for Food Induced Diseases, 
Napoli, Italy.
 
 
3
 Université catholique de Louvain, Louvain Drug Research Institute, WELBIO (Walloon 
Excellence in Life sciences and BIOtechnology), Metabolism and Nutrition research group, 
Brussels, Belgium. 
4 
Institute of Food Sciences, National Research Council, Avellino, Italy. 
 
Running title 
Metabolic effects of different milk 
Grants  
This work was supported by grants from the FNRS and PDR (projet de recherche, Belgium).and 
ERC Starting Grant 2013 (European Research Council, Starting grant 336452-ENIGMO) 
 
Keywords 
mitochondria /microbiota/milk/ redox-status/SCFAs  
 
Corresponding author: 
Maria Pina Mollica 
Università degli Studi di Napoli “Federico II”, Dipartimento di Biologia 
Via Mezzocannone 8, 80134 Napoli 
Tel. 0812535086 Fax: 0812535090 
e-mail: mariapia.mollica@unina.it 
 
List of Abbreviations 
ALT, alanine aminotransferase; CM, cow milk; CPT, carnitine-palmitoyl-transferase; DM, donkey 
milk; FFA, free fatty acid; GSH, glutathione; GSSG, glutathione disulfide; GST, glutathione S-
Transferase; HM,human milk; HOMA, homeostasis model assessment; IL1, interleukin-1; 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
2 
IL10,interleukin-10; LPS , lipopolysaccharide; MCP1, monocyte chemoattractant protein-1; NQO1, 
NAD(P)H:Quinone Oxidoreductase; Nrf2, nuclear factor erythroid-2-related factor-2; OTUs, 
operational taxonomic units; RCR, respiratory control ratio; ROS, reactive oxygen species; SCFAs, 
short-chain fatty acids; TNFα, tumor necrosis factor α; UCP2, uncoupling protein-2. 
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
1 
ABSTRACT 
Different nutritional components are able, by modulating mitochondrial function and gut microbiota 
composition, to influence body composition, metabolic homeostasis and inflammatory state. In this 
study, we aimed to evaluate the effects produced by the supplementation of different milks on 
energy balance, inflammatory state, oxidative stress and antioxidant/detoxifying enzyme activities 
and to investigate the role of the mitochondrial efficiency and the gut microbiota in the regulation of 
metabolic functions in an animal model. We compared the intake of human milk, gold standard for 
infant nutrition, with equicaloric supplementation of donkey milk, the best substitute for newborns 
due to its nutritional properties, and cow milk, the primary marketed product. 
The results showed a hypolipidaemic effect produced by donkey and human milk intake in parallel 
with enhanced mitochondrial activity/proton-leakage. Reduced mitochondrial energy efficiency and 
proinflammatory signals (TNF-α, IL1 and LPS levels) were associated with a significant increase of 
antioxidants (total thiols) and detoxifying enzyme activities (glutathione-S-transferase, NADH 
quinone oxidoreductase) in donkey- and human milk-treated animals.  The beneficial effects were 
attributable, at least in part, to the activation of the nuclear factor-2-erythroid-related-factor-2-
pathway. 
Moreover, the metabolic benefits induced by human and donkey milk may be related to the 
modulation of gut microbiota. In fact, milk treatments uniquely affected the proportions of bacterial 
phyla and genera, and we hypothesised that the increased concentration of faecal butyrate in human 
and donkey milk-treated rats was related to the improved lipid and glucose metabolism and 
detoxifying activities. 
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1. Introduction  
Evidence from animal and human studies indicates that mitochondrial function and gut microbiota 
influence metabolic homeostasis.  
Mitochondria play a central role in cellular function and metabolism by coupling cellular respiration 
to the production of ATP. However, this coupling is not perfectly tight. Approximately 20% of the 
standard metabolic rate in mammals is due to a leak of protons across the mitochondrial inner 
membrane (basal proton leak) in a manner that uncouples cellular respiration from ATP production, 
thereby generating heat [1]. In addition to this basal leak, there is an inducible leak of protons 
catalyzed by free fatty acids (FFAs) [2]. Recent work suggests that an inducible proton leak might 
have an important role in the protection against reactive oxygen species (ROS) [3]. Moreover, 
mitochondria play a key role in cell signaling through production of ROS that modulate redox 
signaling. Nuclear factor E2-related factor-2 (Nrf2) is a transcription factor that orchestrates the 
expression of battery of antioxidant and detoxification genes under both basal and stress condition 
[4]. Nrf2 also modulates genes involved in metabolic regulation, such as fibroblast growth factor 21 
(FGF21), a liver-derived pro-lipolytic hormone and Peroxisome Proliferator-Activated Receptors 
(PPARs), which play an important role in nutrient homeostasis [5]. Notably, the link between 
metabolism, ROS homeostasis and mitochondrial metabolism is further indicated by the role played 
by PPARγ coactivators-1 (PGC-1). Among them PGC-1α plays an important role in mitochondrial 
biogenesis and in the regulation of genes responsible for ROS detoxification [6], while PGC-1β is 
involved in mitochondrial metabolism and its activation exerted a protective effects from lipid 
overload [7]. 
Animal and human studies indicates that the metabolic function develops primarily after birth when 
the newborn is first exposed to nutrition via the gastrointestinal tract and that the composition of the 
gut microbiota influences body composition, digestion and metabolic homeostasis [8,9].  
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Phylogenic changes in gut microbiota composition and the production of bacterial metabolites, 
including short-chain fatty acids, (SCFAs), can interact with reach host tissues to act as metabolic 
regulators and to control energy metabolism and inflammatory state [10]. 
Therefore, nutritional strategies are able, by influencing the mitochondrial function [11,12] and 
microbiota composition, to favour the appropriate development of metabolic and immune system 
functions, and this strategy is now considered a feasible means to prevent diseases such as obesity, 
diabetes and allergies [8,9]. 
Relevance of early nutrition in promoting body growth and health is well established. Human milk 
(HM) is the natural food of all human infants; it provides an adequate supply of all nutrients 
necessary to support growth and development and even has a key role in preventing overweight and 
obesity throughout life in addition to providing immunoregulatory components[13]. Unfortunately, 
a very large population of infants are deprived of their natural food at a proportion that greatly 
exceeds the possible deficiencies of their mothers. The rate of cow milk (CM) consumption in the 
first months of life is high in Western countries, which has been suggested as a potential factor 
contributing to the increasing burden of obesity and related disorders [13]. The overall proportion of 
nutrients contained in CM, such as protein content and quality, fatty acid profile, iron level and the 
near absence of non-digestible carbohydrates, may pose health concerns for children aged < 1 year 
[14]. Moreover, CM intake in the first months of life has raised concerns because of its association 
with allergies [15].  
Consistently during recent years, milks from monogastric animals, rather than from ruminant 
species, have been indicated to be more suitable for human nutrition based on their physicochemical 
properties. Among these, donkey milk (DM) has been suggested as the best potential substitute for 
HM due to its composition [16]. Moreover, as a result of its remarkable nutritional value coupled 
with its reduced allergenicity and good palatability, DM has been suggested as a replacement diet 
for infants affected by CM allergies when HM is not available [17].  
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Comparative data on the metabolic effects of DM and CM, using HM as the reference standard, are 
still scarce. In this study, we aimed to evaluate the differently ability of DM, CM and HM, by 
modulating mitochondrial function and gut microbiota, to affect energy balance, lipid and glucose 
metabolism, inflammatory and oxidative stress in animal model.  
 
2. Materials and Methods 
Male Wistar rats (Charles River, Calco, Lecco, Italy) were individually caged in a temperature-
controlled room and exposed to a daily 12h–12h light–dark cycle with free access to chow and 
drinking water. Young animals (60 days old) (average weight, 345g) were used; one group (n=7) 
was sacrificed at the beginning of the study to establish baseline measurements. The remaining rats 
were divided into 4 experimental groups (n=7): three groups were supplemented with equicaloric 
intake (82kJ) of raw CM, DM or HM (21, 48 or 22 ml/day, respectively) for 4 weeks; the group did 
not receive milk supplement was used as control. Despite the different volumes used, the energy 
density provided by the different milk supplements was comparable (energetic composition of diets 
are reported in Supplementary Table S1 and S2). 
At the end of the treatments, the animals were anaesthetised by intra-peritoneal injection of chloral 
hydrate (40 mg/100 g body weight), and blood was taken from the inferior cava and portal vein. 
The liver was removed and sub-divided; samples not immediately used for mitochondrial 
preparation were frozen and stored at -80°C. 
All experiments were conducted in compliance with national guidelines for the care and use of 
research animals (D.L. 116/92, implementation of EEC directive 609/86).  
2.1 Evaluation of body composition and energy balance 
During the treatments, the body weights and food intake were monitored daily to calculate weight 
gain and gross energy intake. Spilled food and faeces were collected daily for precise food intake 
calculation. Energy balance assessments were conducted over the 4 weeks of treatment by the 
comparative carcass evaluation [18]. Metabolisable energy intake was obtained by subtracting the 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
5 
energy measured in the faeces and urine from the gross energy intake, which was determined from 
the daily food consumption and gross energy density. The gross energy density for the standard 
diet, CM, DM or HM (15.8, 14.04, 13.79 or 14.01 kJ/g, respectively) as well as the energy density 
of the faeces and the carcasses were determined by bomb calorimetry (Parr adiabatic calorimeter, 
Parr Instrument Co., Moline, IL, USA). The evaluation of the energy, fat and protein content in 
animal carcasses was conducted according to a published protocol [18]. Energy efficiency was 
calculated as the percentage of body energy retained per metabolisable energy intake, and energy 
expenditure was determined as the difference between metabolisable energy intake and energy gain. 
2.2 Mitochondrial parameters 
Mitochondrial isolation, oxygen consumption and proton leakage measurements were performed as 
previously reported [19]. Oxygen consumption (polarographically measured using a Clark-type 
electrode) was measured in the presence of substrates and ADP (state 3) and in the presence of 
substrates alone (state 4), and their ratio (respiratory control ratio, RCR) was calculated. The rate of 
mitochondrial fatty acid oxidation was assessed in the presence of palmitoyl-L-carnitine. 
Mitochondrial proton leakage was assessed by a titration of the steady-state respiration rate as a 
function of the mitochondrial membrane potential in liver mitochondria. This titration curve is an 
indirect measurement of proton leakage because the steady-state oxygen consumption rate (i.e., 
proton efflux rate) in non-phosphorylating mitochondria is equivalent to the proton influx rate due 
to proton leakage. The CPT system and aconitase activity were measured spectrophotometrically 
20, 21]. The rate of mitochondrial H2O2 release was assayed by following the linear increase in 
fluorescence due to the oxidation of homovanillic acid in the presence of horseradish peroxidase 
[22].  
2.3 Liver lipid content, redox state and Nrf2-activated enzyme activities  
Total hepatic lipid content was estimated by using the Folch method [23]. Total thiols 
(GSH+GSSG) in plasma and the GSH and GSSG concentrations in the liver were measured with 
the dithionitrobenzoic acid (DTNB)-GSSG reductase recycling assay [24]; the GSH/GSSG ratio 
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was used as an oxidative stress marker. The enzymatic activities of GST and NQO1 were evaluated 
spectrophotometrically in liver cytoplasmic extracts with standard protocols [25-27].  
2.4 Quantitative real-time PCR analysis 
Total RNA was extracted from liver of rats fed with the different milk (CM, DM, HM) and of 
control rats using the TRIzol Reagent (Ambion). After DNase treatment (Ambion), RNA was 
quantified using a Nanodrop 2000c spectrophotometer (ThermoScientific) and reverse-transcribed 
(1 µg) using the Advantage RT-PCR kit (Clontech) and oligo dT primer. Universal Probe Library 
Assay Design Center (https://www.roche-applied-cience.com/sis/rtpcr/upl/index.jsp?id=UP030000) 
was used for designing primers (Supplementary Table S3). The Real Time-PCR reactions were 
performed using a 7500 Real-Time PCR System (Applied Biosystems) in the presence of 1X Power 
Sybr Green PCR Master mix (Applied Biosystems) and 0.1 μM of each primer and 30 ng of cDNA. 
The thermal protocol was as follows: 2 min at 50°C, 10 min at 95°C, followed by 40 cycles of 15 
sec at 95°C and 1 min at 60°C. For all of the genes examined, the reactions were conducted in 
technical duplicates. For each well, the evaluation of PCR efficiency (E) and optimal threshold 
cycle (CT) of the target genes (PGC1α, PGC1β, PPARα, PPARβ, FGF21) and the endogenous 
control gene (β-actin) were performed using the REAL TIME PCR MINER online tool [28]. The 
mean relative expression ratio (rER) of the target genes was calculated using β-actin as the 
endogenous control gene and cDNA of the control ratsas the reference sample applying the formula:  
rER = (1 + E target gene
)-ΔCT target gene
/(1 + E endogenous control)
-ΔCT endogenous control 
, where ΔCT 
target gene is the difference between the CT value of the target gene in the liver of the CM, DM, 
HM rats and the CT value of the target gene in the liver of the control rats, ΔCT endogenous control is the 
difference between the CT value of the β-actin gene in liver of the CM, DM, HM rats and the CT 
value of the β-actin gene in the liver of the control rats [29]. 
2.5 Preparation of faecal extracts 
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Faeces were collected and were frozen at -20°C. Frozen faeces were diluted with saline solution and 
centrifuged at 13,000rpm for 10min. Supernatants were filtered (0.45 µM) and used as the faecal 
extracts. These extracts were stored at -20°C until further analysis. 
2.6 Quantification of faecal short-chain fatty acid (SCFAs)  concentrations 
Frozen faecal extracts were acidified with 20µl 85% phosphoric acid and 0.5ml ethyl acetate. The 
contents were mixed by vortexing, centrifuged at 14,000rpm for 1h and extracted in duplicate. A 
quantity of the pooled extract containing the acidified SCFAs was transferred into a 2ml glass vial 
and loaded onto an Agilent technologies 7890 gas-chromatography system with an automatic 
loader/injector. The GC column was an Agilent J&W DB-FFAP (Agilent Technologies, Leini, TO, 
Italy) of length 30m, internal diameter 0.25mm, and film thickness 0.25µm. The GC was 
programmed to achieve the following run parameters: initial temperature 90°C, hold 0.5min, ramp 
20°C/min, final temperature 190°C, total run time 8.0 min. Gas flow was set at 7.7 ml/min splitless 
to maintain 3.26 psi column head pressure with a septum purge of 2.0 ml/min. Detection was 
achieved using a flame ionisation detector. Peaks were identified using a mixed external standard 
and quantified by the peak height/internal standard ratio. 
2.7 Microbiota analysis: DNA isolation and sequencing 
The caecal contents of rats collected post-mortem were stored at -80°C. Metagenomic DNA was 
extracted from the caecal contents using a QIAamp-DNA stool mini-kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions and the adapted procedure described by Dewulf [30]. 
High-throughput sequencing of metagenomic samples was performed by DNAVision (Gosselies, 
Belgium). Briefly, the V1-V3 region of the bacterial 16S rRNA gene was amplified using barcoded 
primers 27f (5’-CCTATCCCCTGTGTGCCTTGGCAGTCTCAG-3’) and 534r (5’-
ATTACCGCGGCTGCTGG-3’) [31], and purified amplicons were analysed on a Roche FLX 
Genome Sequencer using titanium chemistry. The resulting Q25 reads were processed through the 
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8 
QIIME v1.7.0 pipeline [32]. Sequences were depleted of barcodes and primers, sequences <200bp 
or >1000bp were removed, sequences with ambiguous base calls were removed, and sequences with 
homopolymer runs exceeding 6bp were removed. The sequences were then de-noised, and chimeras 
were removed. Operational taxonomic units (OTUs) were defined by clustering at 3% divergence 
(97% similarity). The OTUs were then taxonomically classified using BLASTn against a curated 
GreenGenes database. 
 
2.8 Statistical analyses  
Data are presented as the means±SE unless otherwise indicated.. Differences among groups were 
compared by ANOVA followed by the Newman-Keuls test to correct for multiple comparisons. 
Differences were considered statistically significant at P<0.05. Analyses were performed using 
GraphPad Prism (GraphPad Software, San Diego, CA, USA). 
For microbiota analyses, data are expressed as the means±SD. Differences between groups were 
assessed using a two-tailed Student t-test. In the case of non-detectable values for some samples, a 
non-parametric test was required, such as Fisher’s exact test to compare two groups at a time. 
Because most of the parameters had an abnormal distribution (assessed using a Shapiro normality 
test), the correlations were analysed by Spearman’s correlation. Data were analysed using JMP 
8.0.1 (SAS Institute, Inc., Cary, NC, USA), R 3.0.2 (The R Foundation) and RStudio 0.97.310 with 
the package gplots for the heatmap. The results were considered statistically significant at P<0.05. 
3. RESULTS 
3.1 Body composition and energy balance  
Although different milk treatments provided similar metabolisable energy intake (Fig. 1D), we 
found that CM-treated animals exhibited an increase in body weight gain (Fig. 1E) and body lipids 
percentage (Fig. 1A) compared to control, whereas the same parameters of DM- or HM-treated 
animals were similar to control. A significant increase in body protein content was observed in HM-
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9 
treated rats (Fig. 1B). In DM and HM groups, we observed an increased energy expenditure (Fig. 
1F). Finally, the gross energy efficiency was significantly increased in CM-treated and significantly 
decreased in DM-treated animals compared to control animals. This parameter was not affected in 
HM-treated animals (Fig. 1G). The enhanced energy efficiency in CM-treated animals was 
associated with higher lipid gain (Fig. 1H). In contrast, this parameter was markedly reduced in 
DM- and HM-treated animals compared to controls. Protein gain (Fig. 1I) was significantly 
decreased in DM-treated animals and increased in the other two groups, compared to control. In 
particular, HM-treated animals showed a greater increase compared to the control. 
 
3.2 Serum metabolites and inflammatory parameters  
Serum glucose levels were significantly lower in HM- and DM-fed rats than in the other animals, 
HM-fed rats showed the lowest insulin concentration among the groups. Consequently, a marked 
reduction of homeostasis model assessment (HOMA) index was observed in the DM and HM 
groups compared to controls, with HM producing the lowest HOMA index (Table 1). Total 
cholesterol levels were not affected by the different milks, however, triglycerides were significantly 
decreased in DM-fed animals and ALT was significantly decreased in HM-fed animals (Table 1). 
TNF-α, IL1 and LPS concentrations were significantly decreased in HM- and DM-fed animals 
compared to control and CM-fed rats, whereas MCP1 levels resulted unaffected by the different 
milks. IL10 was increased by two- to three-fold in the treatment groups (HM>DM>CM) compared 
to control (Table 2). 
 
3.3 Mitochondrial efficiency and oxidative stress  
Mitochondrial state 3 respiration using succinate or palmitoyl-carnitine (fatty acid oxidation) as a 
substrate was increased in CM-treated animals and further increased in DM- and HM-treated 
animals compared to controls (Fig. 2A-2C). State 3 respiration using glutamate (Fig. 2B) as 
substrate and CPT activity (Fig. 2D) were increased in DM- and HM-treated animals compared to 
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control and CM-treated rats. RCR values were indicative of high-quality mitochondrial preparations 
(data not shown). 
After 4 weeks of treatment, the specific activity of citrate synthase in isolated mitochondria was 
unchanged, whereas in liver homogenates, the activity was higher in DM-treated animals and 
further increased in HM-treated animals compared to control and CM-treated rats (Fig. 2E). 
Therefore, a significantly higher mitochondrial protein contents (calculated as the ratio between 
citrate synthase activity in the homogenate and isolated mitochondria) found in HM- and DM-
treated rats (HM>DM) indicate that the improved oxidative capacity appears to be supported (at 
least in part) by an increased mitochondrial mass (Fig. 2E). Mitochondrial basal and free fatty acid 
(FFA)-induced proton-leakage was increased in milk-treated animals (Fig. 2F-G) compared to 
control. The effect on mitochondria basal leakage was related to the type of milk used 
(HM>DM>CM) (Fig. 2F). In particular, HM-treated animals exhibited the highest oxygen 
consumption to maintain the same membrane potential among the groups. In FFA-induced proton-
leakage conditions, mitochondria from DM- and CM-treated rats exhibited comparable kinetic 
curves (Fig. 2G). UCP2 significantly increased after milk treatments, but this effect was more 
pronounced in DM-treated animals (Fig. 2H). 
Next, H2O2 yield and ROS-induced damage were measured in mitochondria. H2O2 yield was 
significantly increased in CM-treated rats and was reduced in mitochondria from the HM and DM 
groups (HM>DM) (Fig. 2I). Aconitase activity was significantly increased in DM and HM-treated 
rats compared to CM and control rats (HM>DM) (Fig. 2L). 
  
3.4 Antioxidant/detoxifying defences  
Antioxidant state and cytoprotective enzyme activities are improved by dietary supplementation 
with DM or HM. We measured the total protein thiols in the serum, we found a two-fold increase in 
total GSH levels in the sera from HM-treated animals (0.199±0.008 nmoles/mg-protein/min) 
compared to controls (0.101±0.003); to a lesser extent, we also found an increase of total GSH in 
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CM- and DM-supplemented rats (0.128±0.002 and 0.154±0.014 nmoles/mg-protein/min). At 
hepatic level, CM-treated rats exhibited a significantly higher percentage of lipids compared to 
other groups (Fig. 3A). Reduced GSH levels were significantly increased in animals supplemented 
with DM or HM compared to CM-treated or control rats (HM=DM>CM=C) (Fig. 3B). Moreover, 
the beneficial effects produced by the HM and DM treatments on liver redox status were clearly 
indicated by the marked decline in the GSSG content and the significantly increased GSH/GSSG 
ratios (Fig. 3C-D). In addition, the activity of NQO1 and GST was significantly higher in DM- or 
HM-treated rats compared to CM-treated or control rats (Fig. 3E-F). In addition, because Nrf2 
activation was demonstrated to induce the expression of metabolic genes (PPARs, FGF21) [5], we 
analysed the expression of the PPARα, PPARγ, PGC1α, PGC1β and FGF21 genes. No variation 
was observed in the expression levels of PPARα, PPARγ (data not shown) The FGF21 mRNA 
levels in DM and HM were significantly decreased compared with CM rats (Fig. 3G). The CM rats 
tended to increase the FGF21 mRNA levels in the liver, compared with control.. However, this 
difference was not statistically significant (Fig. 3G). PGC1-α and PGC1-β mRNA levels 
significantly increased in CM compared to the other groups (Fig 3H-3I). 
3.5 Gut microbiota composition 
Gut microbiota composition was analysed by pyrosequencing. Bacteroidetes was increased in CM-
fed rats (+22%) and Verrucomicrobia was decreased in DM-fed rats (-58%) compared to control. 
TM7 was increased (+575%) in DM-fed rats compared to CM-fed rats (Fig. 4).. Data on phylum 
differences are provided in Supplementary Table S4. 
The abundances of 10 genera were significantly affected by milk treatments (Fig. 5). DM and HM 
similarly modified gut microbiota at genera level (Supplementary Table S5).  
The potential link between changes in gut microbiota composition and host metabolic parameters 
following different milk treatments was evaluated by a Spearman correlation coefficient (Fig. 6). 
Streptococcus and Lactococcus genera (increased in DM) and Coprobacillus and Parabacteroides 
(increased in HM) were negatively correlated with inflammatory markers (LPS and TNF-α) and 
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fasting blood glucose (Fig. 6). Moreover, these genera were positively correlated with faecal 
butyrate content, mitochondrial respiratory capacity and fatty acid oxidation rate (Fig. 6). In 
contrast, Akkermansia abundance was positively correlated with fasting blood glucose, TNF-α and 
LPS levels. Changes in Blautia and Syntrophococcus genera were both positively correlated with 
antioxidant and anti-inflammatory markers (serum GSH and IL-10). Blautia abundance (increased 
by all milks) was positively correlated with faecal butyrate, mitochondrial respiratory capacity and 
fatty acid oxidation rate. In addition, the significant increase of Syntrophococcus by HM 
(Supplementary Table S5) was positively correlated with energy expenditure and body protein 
content (Fig. 6). 
 
3.6 SCFAs production  
An increase in faecal butyrate and propionate levels was observed in animals treated with DM or 
HM, but not CM, compared with control rats. The effect was two-fold greater in DM-treated 
compared with HM-treated animals (Fig. 7). 
 
4. DISCUSSION  
In this study, we compared the nutritional, immunomodulatory and antioxidant effects of iso-
energetic supplementation with milk from three distinct animals: two that are monogastric (HM and 
DM) and one that is polygastric (CM). We recently showed the efficacy of DM in decreasing the 
accumulation of body lipids and its ability to improve the use of fat as metabolic fuel for hepatic 
mitochondria [33]. Here, we demonstrate that these biological effects are comparable with those 
elicited by HM. Although these different milks resulted in similar increases in metabolisable 
energy, DM and HM had no effect on body weight gain but were able to increase energy 
expenditure compared with CM. The enhanced energy efficiency found in CM-fed animals was 
associated with higher total body and liver lipid levels; in contrast, these values were markedly 
reduced in DM-and HM-fed animals. In HM-fed rats, it is likely that the decrease in adiposity can 
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be explained by increased fatty acid oxidation; however, we cannot exclude that this effect may also 
be due to lower plasma insulin levels. The roles that essential fatty acids, enzymes, hormones, 
growth factors and other biologically active compounds play in the effects of HM and DM on lipid 
metabolism merit further consideration. The observed differences in body protein content suggest 
some interesting perspectives. The quality of proteins, with respect to their essential amino acid 
content, may be responsible for the difference observed. However, we cannot rule out that this 
effect on protein gain may also be due to the high concentration of growth factors in HM that are 
essential for the proliferation and differentiation of body tissues [34].  
The current study highlights the ability of HM to control glucose homeostasis by inducing a 
dampened glycaemic response compared to CM and the lowest insulin levels and HOMA index 
compared to other milks. These results are consistent with Gunnerud et al. [35]. Other data show 
that the insulin response to milk is not only due to the lactose component but is also related to the 
whey fraction [36], and to bioactive peptides in the milk or secreted in the gastrointestinal tract [37]. 
Moreover, glucose-regulating hormones, such as leptin, adiponectin, resistin and ghrelin, detected 
in HM [38], may be involved in the regulation of growth in infancy and might influence the 
programming of energy balance with long-term consequences on health [13]. Other studies 
highlight the correlation between low blood glucose and insulin in infancy and low insulin levels in 
adulthood, suggesting a protective role of breastfeeding against type 2 diabetes and obesity in later 
life [39]. It is noteworthy that in the rat model, DM affects glucose metabolism in a manner more 
similar to HM than CM, suggesting that in addition to providing a hypoallergenic milk substitute 
for children affected by CM protein allergies, DM might have beneficial effects by changing energy 
homeostasis in favour of fatty acid oxidation, thereby reducing fat storage. However, this 
speculation warrants further investigation in humans. Moreover, the metabolic benefits on body 
weight and glucose control induced by HM and DM may be related to the modulation of the gut 
microbiota. We and others have previously shown that the gut microbiota plays a major role in 
energy storage and glucose homeostasis [40,41]. Among the metabolites produced by the gut 
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microbiota, SCFAs have been shown to play a major role [42,43]. We can speculate that the marked 
increase in SCFAs in both DM- and HM-treated rats can be responsible, at least in part, to 
beneficial effects found in these animals. Finally, the effects of SCFAs have been described in 
several studies and have been shown to reduce diet-induced obesity and to increase energy 
expenditure [42-44]. 
The effect of different milks on nutritional status is controlled by multiple mechanisms. Considering 
the central role of the liver in energy expenditure and lipid and glucose metabolism, we evaluated 
hepatic mitochondrial function and efficiency. 
We observed similar biological responses in rats fed with DM or HM; in particular, the beneficial 
effects of DM administration are further enhanced in rats treated with HM. HM-fed rats exhibited 
increased respiratory capacity and mitochondrial mass and decreased oxidative stress in their liver 
mitochondria even when the ability to utilise fat as a metabolic fuel was increased. The increased 
mitochondrial fatty acid oxidation observed in the liver is likely related to an enhancement of CPT 
activity, which would further increase the entry of long-chain FFAs into the mitochondria. The 
consequent increase in lipid oxidation is apparently sufficient to handle the decreased load of 
hepatic FFAs and body adiposity. 
A concomitant decline in mitochondrial energy efficiency (thermogenic effect), as evidenced by the 
increased proton-leakage and increased UCP2 protein content in HM-fed rats, may also contribute 
to burning the fat in these animals. Indeed, in addition to stimulating fatty acid oxidation in the 
liver, HM induced a less efficient utilisation of lipid substrates through the stimulation of a 
thermogenic mechanism, such as proton-leakage. We speculate that HM-fed animals (similarly to 
DM-treated rats) might be protected from the development of obesity through this mechanism; 
however, this hypothesis requires further investigation. In addition, the reduction of mitochondrial 
oxidative stress parameters (H2O2 production and aconitase activity) can result from the 
concomitant increase in proton-leakage, which was reported as a major mechanism involved in the 
modulation of membrane potential to control mitochondrial ROS emission [3]. The observed 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 
15 
beneficial effects elicited by DM intake on the antioxidant status (GSH/GSSG ratio) and on 
detoxifying enzyme activities (GST-NQO1) confirm previous findings [33]. Notably, the 
comparable enhancement of antioxidant/detoxifying defences by DM and HM intake is attributable, 
at least in part, to the activation of the Nrf2–ARE pathway and further supports the feasibility of 
DM as an ideal HM substitute. Moreover, Nrf2 may exert a control on the stress hormones FGF21 
[45], an important factor in the homeostatic mechanisms regulating glucose and lipid metabolism 
[46]. Importantly, the activation of Nrf2 in DM and HM rats is significantly associated with lower 
mRNA expression levels of FGF21, whereas the increased FGF21 expression in CM group if 
compared to DM or HM rats, together with high hepatic lipid content and H2O2 yield, is in line with 
the expression of PGC1 that in previous studies was showed necessary for the FGF21 protective 
effects in liver damage conditions, regulates ROS homeostasis and mitochondrial biogenesis [47]. 
Moreover, due to the recognition of the gut-liver axis and on the basis of the recent studies reporting 
the in vivo and in vitro ability of butyrate to modulate the Nrf2-ARE pathway [48,49], our data 
showing increased concentrations of faecal butyrate in HM- and DM-treated rats led us to 
hypothesise that an improved Nrf2 defence may result from the increased levels of butyrate-
producing microbiota in these animals. Finally, the reported association of enhanced anti-
inflammatory defences with Nrf2 signalling [50] prompted us to evaluate the consequences of DM 
and HM intake on the levels of several proinflammatory indicators. The beneficial effects produced 
by HM and DM intake were indicated by lower TNF-α and IL1 concentrations, decreased LPS 
levels (marker of metabolic and inflammatory diseases) [44] and increased IL10. 
Here, we investigated the impact of CM, DM and HM dietary supplementation on the gut 
microbiota composition. We found that DM and HM affected the gut microbiota in favour of two 
genera that have been linked with anti-inflammatory properties: Bacteroides and Parabacteroides. 
Importantly, these bacterial species are known to produce SCFAs [51]. It is worth noting that we 
found an increased level of faecal SCFAs in animals fed with DM and HM. Recent evidence 
suggests that the genus Parabacteroides may be associated with an improved intestinal integrity 
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and a lower inflammatory tone [52]. In agreement, we also found (by Spearman correlation) that 
Parabacteroides abundance was negatively associated with several inflammatory markers. 
Moreover, an increase of Syntrophococcus and Blautia genera in milk-treated rats was observed. 
Interestingly, these two genera were correlated with different biological parameters. For instance, 
Syntrophococcus, which was increased in the HM-treated group, is positively related to body 
protein content and gain, whereas Blautia, which was significantly increased in the DM-treated 
group, is positively associated with mitochondrial respiratory capacity. It is worth noting that in 
patients affected by hepatic encephalopathy, the presence of Blautia was associated with good 
cognition, lower severity of liver disease and decreased inflammation [53]. We did not find any 
differences among the groups in Lactobacillus genera; however, we observed a significantly higher 
rate of Streptococcus and Lactococcus in DM-treated rats than in other groups. It was previously 
shown that a probiotic combination containing Streptococcus thermophilus protects the bowel and 
improves colonic inflammation in experimentally induced inflammatory bowel disease in rats [54] 
Our findings support this hypothesis because Streptococcus and Lactococcus were negatively 
correlated with inflammatory parameters (TNF-α, LPS and H2O2 yield). We also analyzed 
Akkermansia rate.  This species was isolated from the human intestinal tract due to its efficient use 
of mucus as a carbon and nitrogen source and it is associated with the protective mucosal lining of 
the intestine. We and others have previously shown that A. muciniphila abundance is correlated 
with an improved metabolic profile [55,56]. In addition, it was demonstrated that A. muciniphila 
treatment reversed high fat diet-induced metabolic disorders by restoring the gut mucus layer that is 
disrupted with obesity and type 2 diabetes [55]. It is likely that A. muciniphila regulates gut barrier 
function at different levels. Excessive mucin degradation by intestinal bacteria may contribute to 
inflammatory bowel diseases because the access of luminal antigens to the intestinal immune 
system is facilitated, whereas in pathological conditions, A. muciniphila seems to improve intestinal 
response by increasing mucus production and the number of goblet cells [55]. In this study, no 
increase of Akkermansia was found in the treated groups; instead a significant reduction of its 
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presence was observed in DM-treated rats and was positively correlated with fasting glucose, TNF-
α and LPS levels. Whether the beneficial effects of the different milks observed in our study are 
mediated through this genus warrants further investigation. 
The present study highlights that dietary supplementation with HM or DM is associated with a 
decrease of inflammatory status. This decrease is associated with the improvement of lipid and 
glucose metabolism. In addition, our observations indicate that the beneficial effects elicited by HM 
and DM are, at least in part, mediated by their ability to modulate mitochondrial function and 
efficiency, ROS homeostasis and Nrf2 – FGF21 pathways. Moreover, we found that specific gut 
microbes and metabolites (SCFAs) were increased upon HM and DM feeding, thereby linking gut 
microbiota with host metabolism (Fig 8) .  
Altogether, our study adds further support to the exceptional qualities of HM and DM compared to 
CM. Thus, the impact of milk from ruminants differs from that of monogastric species on gut 
microbes and host metabolism at different levels (energy storage, energy expenditure, 
mitochondrial function, metabolism and inflammation). Whether the physicochemical and 
nutritional properties can explain the distinctive nutritional, sensory and metabolic characteristics 
among the different milks requires further studies. Finally, nature provided humans, just as all 
mammalian species, with a milk especially suited not only to the nutritional needs of the respective 
infants but also to the promotion of future health and development. Nevertheless, by displaying 
novel mechanisms linking gut microbes and mitochondrial function with cellular metabolic 
responses according to the milk used, this study adds novel significant perspectives and suggests 
that selected milks may provide protection against specific metabolic disorders. 
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Figure legends 
Figure 1. Body composition and energy balance 
Body lipid (A), body protein (B), body water content (C), metabolisable energy intake (D), body 
weight gain (E), energy expenditure (F), gross efficiency (G), lipid gain (H) and protein gain (I) 
were reported. The results are expressed as the means±SE from n=7 animals/group. Different 
superscripted letters indicate statistically significant differences (P<0.05). 
 
Figure 2. Coupling efficiency in the liver mitochondria  
Liver mitochondrial respiration rates were evaluated in the presence of succinate (A), glutamate (B) 
or palmitoyl-carnitine (C) substrates. Carnitine-palmitoyl transferase (CPT) activity was reported 
(D). Citrate synthase (CS) activity was measured in the liver homogenate and mitochondrial 
fractions; the mitochondrial protein mass was calculated as the ratio between CS activity in the 
homogenate and isolated mitochondria (E). Basal (F) and fatty acid-induced proton-leakage (G) 
was measured in liver mitochondria. Representative immunoblot of UCP2 expression in liver 
mitochondria; the bands were quantified by densitometry. The values are expressed as relative 
intensity in arbitrary units (H). Intracellular H2O2 yield (I) and the basal aconitase/total aconitase 
ratio are reported (L). The results are expressed as the means±SE from n=7 animals/group. 
Different superscripted letters indicate statistically significant differences (P<0.05). 
 
Figure 3. Redox status and antioxidant/detoxifying defences  
Total lipid (A), GSH (B) and GSSG content (C), GSH/GSSG ratio (D), GST (E) NQO1 activity 
(F), relative mRNA expression of FGF21 (G), PGC1α (H), PGC1β (I) were measured in the livers 
of differently treated rats. The results are expressed as the means±SE from n=7 animals/group. 
Different superscripted letters indicate statistically significant differences (P<0.05).  
 
Figure 4. Milk treatments affect the proportions of different phyla 
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The composition of abundant bacterial phyla identified in gut microbiota of control and different 
milk-treated animals. Undetected phyla are not represented on the pie chart. The significant 
differences in specific phyla are shown in Supplementary Table 4. 
 
Figure 5. Milk treatments affect the proportions of different genera  
The composition of the bacterial genera significantly affected by the treatments and identified in gut 
microbiota of control and different milk-treated animals. Each bar is set at 100% to illustrate the 
proportion of each genera among the different groups; the absence of any colour indicates that the 
genus was not detected in this group of rats. Statistically significant changes observed between 
different groups are shown in Supplementary Table 5. 
 
Figure 6. Spearman correlations heat map Heat map of the Spearman r correlations between the 
gut bacteria modified by the different milk supplements and biological parameters. Correlations 
were performed on values for each rat in every group. 
 
Figure 7 SCFAs concentrations Faecal butyrate (A) and propionate (B) levels were reported. The 
results are expressed as the means±SE from n=7 animals/group. Different superscripted letters 
indicate statistically significant differences (P<0.05). 
 
Figure 8 Model depicting the effects of distinct milks supplementation on, lipid and glucose 
metabolism, inflammatory and oxidative stress by modulating mitochondrial function and gut 
microbiota 
To assess the effects of distinct milks supplementation on energy balance and redox state, it is 
crucial to understand how mitochondrial function and gut microbiota composition interact with host 
and participate in the metabolic response to diet. The modulation of Nrf2 pathway and the bacterial 
metabolism of nutrients in the gut, with the release of bioactive compounds (SCFAs), promote 
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competitive interactions with host cellular targets to control energy metabolism and inflammatory 
state.Nrf2 pathways is induced by DM and HM and leads to a decrease in FGF21 expression. In 
contrast,  in CM rats the lacking activation of Nrf2 abolishes its inhibitory effect on FGF21 
modulating mitochondrial biogenesis by PGC1. DM and HM affect gut microbiota composition 
with an increase in SCFAs which in turn modulate Nrf2.The correlation between gut microbiota and 
inflammatory parameters are confirmed by Sperman analyses  
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Fig. 5 
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Fig. 6 
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Fig. 7 
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Fig. 8 
TABLE 1Serum parameters 
 
 
 Control CM DM HM 
Glucose mg/dl 138.6±2.1
 a
 130.1±5.7
 a
 112.1±2.7
 b
 112.7±3.7
 b
 
Insulin μg/l 0.273±0.018 a 0.274±0.019 a 0.271±0.019 a 0.201±0.013 b 
HOMA index 2.19±0.12
 a
 2.09±0.13
 a
 1.75±0.12
 b
 1.314±0.10
 c
 
Triglycerides, mg/dl 116±5.3
 a
 132±7.5
 a
 90±4.1
 b
 120±5.2
 a
 
Tot. Cholesterol, mg/dl 61±1.6
 a
 63±1.1
 a
 58±1.2
 a
 59±1.5
 a
 
ALT, U/l 67±2.0
 a
 71±3.2
 a
 62±2.0
 a
 44±2.6
 b
 
 
Abbreviations: HOMA: homeostasis model assessment; ALT: alanine aminotransferase. Data are the means ± SE. Data 
with different superscripted letters are significantly different (p<0.05). 
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TABLE 2 
 
Immunomodulatory markers 
 
 
 Control CM DM HM 
TNFα, ng/ml 0.092±0.006 a 0.090±0.005 a 0.055±0.005 b 0.058±0.005 b 
MCP1, ng/ml 3.62±0.15
 a
 3.82±0.22
 a
 3.29±0.22
 a
 3.87±0.32
a
 
IL1, pg/ml 56.4±3.3
 a
 64.0±2.1
 a
 42.9±3.4
 b
 42.2±3.9
 b
 
IL10, ng/ml 0.061±0.003
 a
 0.134±0.008
 b
 0.177±0.012
 c
 0.200±0.005
 d
 
LPS, EU/ml 0.704±0.028
a 
0.668±0.025
a
 0.584±0.014
b 
0.580±0.015
b 
 
Abbreviations: TNF-α: tumour necrosis factor-α; MCP-1: monocyte chemo attractant protein-1; IL1: interleukin-1; 
IL10: interleukin-10; LPS: lipopolysaccharides. Data are the means ± SE. Data with different superscripted letters are 
significantly different (p<0.05).
